Advice regarding Xolair (omalizumab) claiming

Megan Haggan 08/08/2025

The Department of Health and Aged Care has released advice noting that it is aware of the issues with prescribing and claiming omalizumab PBS items since 1 August 2025 For existing omalizumab prescriptions dated prior to 1 August 2025, approved suppliers can dispense either 150mg syringe Omlyclo [EW] or 150mg pen device Xolair [NV], it

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Advice regarding Xolair (omalizumab) claiming

Previous The week in review

Next CWH, Amcal dig deep for charities

MENU

ajp.com.au

Previous The week in review

Next CWH, Amcal dig deep for charities

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.